No Guarantee of Success. Biogen and AGTC acknowledge and agree that nothing in this Agreement will be construed as representing any estimate or projection of (a) the successful Development or Commercialization of any Licensed Product under this Agreement, (b) the number of Licensed Products that will or may be successfully Developed or Commercialized under this Agreement, (c) anticipated sales or the actual value of any Licensed Products that may be successfully Developed or Commercialized under this Agreement or (d) the damages, if any, that may be payable if this Agreement is terminated for any reason. Neither Party makes any representation, warranty or covenant, either express or implied, that (i) it will successfully Develop, Manufacture, Commercialize or, other than is expressly required under Section 3.3.1, Section 4.3.1 or 8.3.1, continue to Commercialize any Licensed Product in any country, (ii) if Commercialized, that any Licensed Product will achieve any particular sales level, whether in any individual country or cumulatively throughout the Territory or (iii) other than is expressly required under Section 3.3.1, Section 4.3.1 and Section 8.3.1, that either Party will devote, or cause to be devoted, any level of diligence or resources to Developing or Commercializing any Licensed Product in any country, or in the Territory in general.
Appears in 2 contracts
Samples: Collaboration and License Agreement (Applied Genetic Technologies Corp), Collaboration and License Agreement (Applied Genetic Technologies Corp)
No Guarantee of Success. Biogen Collegium and AGTC BDSI acknowledge and agree that nothing in this Agreement will be construed as representing any estimate or projection of (ai) the successful Development or Commercialization of any Licensed Product under this Agreement, (bii) the number of Licensed Products that will or may be successfully Developed or Commercialized under this Agreement, (ciii) anticipated sales or the actual value of any Licensed Products that may be successfully Developed or Commercialized under this Agreement or (div) the damages, if any, that may be payable if this Agreement is terminated for any reason. Neither Party makes any warranties, express or implied, or covenants concerning the success of the Development or Commercialization of any Licensed Products or the commercial utility, merchantability, or fitness for a particular purpose of any Licensed Product. In addition, Collegium makes no representation, warranty or covenant, either express or implied, that (iA) it will successfully Develop, Manufacture, Develop or Commercialize or, other than is expressly required under Section 3.3.1, Section 4.3.1 or 8.3.1, continue to Develop or Commercialize any Licensed Product in any countrythe Territory, (iiB) if Commercialized, that any Licensed Product will achieve any particular sales level, whether level in any individual country or cumulatively throughout the Territory or (iiiC) other than is expressly required under Section 3.3.1, Section 4.3.1 and Section 8.3.1, that either Party it will devote, or cause to be devoted, any level of diligence or resources to Developing or Commercializing any Licensed Product in any countrythe Territory, or in the Territory in generalother than is expressly required under Sections 2.02 and 5.01(a) and Article VI.
Appears in 2 contracts
Samples: License and Development Agreement (Collegium Pharmaceutical, Inc), License and Development Agreement (Biodelivery Sciences International Inc)
No Guarantee of Success. Biogen LICENSEE and AGTC acknowledge and agree that nothing in this Agreement will be construed as representing any estimate or projection of (a) the successful Development or Commercialization of any Licensed Product under this Agreement, (b) the number of Licensed Products that will or may be successfully Developed or Commercialized under this Agreement, (c) anticipated sales or the actual value of any Licensed Products that may be successfully Developed or Commercialized under this Agreement or (d) the damages, if any, that may be payable if this Confidential Agreement is terminated for any reason. Neither Party makes any representation, warranty or covenant, either express or implied, that (i) it will successfully Develop, Manufacture, Commercialize or, other than is expressly required under Section 3.3.1, Section 4.3.1 or 8.3.1Article VI, continue to Commercialize any Licensed Product in any country, (ii) if Commercialized, that any Licensed Product will achieve any particular sales level, whether in any individual country or cumulatively throughout the Territory or (iii) other than is expressly required under Section 3.3.1, Section 4.3.1 and Section 8.3.1Article VI, that either Party will devote, or cause to be devoted, any level of diligence or resources to Developing or Commercializing any Licensed Product in any country, or in the Territory in general.
Appears in 1 contract
Samples: Manufacturing License and Technology Transfer Agreement (Applied Genetic Technologies Corp)
No Guarantee of Success. Biogen LICENSEE and AGTC acknowledge and agree that nothing in this Agreement will be construed as representing any estimate or projection of (a) the successful Development or Commercialization of any Licensed Product under this Agreement, (b) the number of Licensed Products that will or may be successfully Developed or Commercialized under this Agreement, (c) anticipated sales or the actual value of any Licensed Products that may be successfully Developed or Commercialized under this Agreement or (d) the damages, if any, that may be payable if this Agreement is terminated for any reason. Neither Party makes any representation, warranty or covenant, either express or implied, that (i) it will successfully Develop, Manufacture, Commercialize or, other than is expressly required under Section 3.3.1, Section 4.3.1 or 8.3.1Article VI, continue to Commercialize any Licensed Product in any country, (ii) if Commercialized, that any Licensed Product will achieve any particular sales level, whether in any individual country or cumulatively throughout the Territory or (iii) other than is expressly required under Section 3.3.1, Section 4.3.1 and Section 8.3.1Article VI, that either Party will devote, or cause to be devoted, any level of diligence or resources to Developing or Commercializing any Licensed Product in any country, or in the Territory in general.
Appears in 1 contract
Samples: Manufacturing License and Technology Transfer Agreement (Applied Genetic Technologies Corp)